Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00301249 · ClinicalTrials.gov registry record
The Family Investigation of Nephropathy and Diabetes Study
A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 9,031
- Enrollment target
NCT00301249: Completed study, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00301249 is a clinical trial that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 9,031 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00301249 has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 9,031 participants
- Enrollment target
Study Summary
The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic nephropathy, establish a secure master FIND database, and perform a genome scan to identify chromosomal regions linked with diabetic nephropathy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,031 participants |
| Start Date | 1999-10 |
| Est. Completion | 2006-12 |
What the finished NCT00301249 record still lists
NCT00301249 is an observational study that tracks outcomes without assigning an intervention. Its 9,031 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00301249 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00301249 about?
NCT00301249 is a clinical study titled "The Family Investigation of Nephropathy and Diabetes Study". The Family Investigation of Nephropathy and Diabetes (FIND)Study is a multi-center consortium. The charge of the consortium is to acquire sets of families with well-characterized diabetic nephropathy, establish a secure master FIND database, and perform a genome scan to identify chromosomal regions ...
What is the current status of trial NCT00301249?
This trial is currently completed. The enrollment target is 9,031 participants. The study started on 1999-10. Estimated completion is 2006-12.
Who is sponsoring clinical trial NCT00301249?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02000089 · 9,000 participants · Phase 3
The Cancer of the Pancreas Screening-5 CAPS5)Study
- NCT05612347 · 8,946 participants · NA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- NCT06946355 · 9,119 participants · NA
Food-based Support for Hospitalized Children and Their Families
- NCT05336877 · 8,744 participants
Aveir VR Coverage With Evidence Development Post-Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia